The United Kingdom’s Healthtech and Medtech sectors are approaching a definitive inflection point as the market transitions into 2026. Following a period characterised by post-pandemic market corrections, valuation compression and capital scarcity between 2023 and 2025, the outlook for 2026 is one of strategic acceleration and structural evolution. This report predicts that 2026 will not merely represent a cyclical rebound but a fundamental shift in the operating logic of